High intake of dietary advanced glycation end-products is associated with increased arterial stiffness and inflammation in subjects with type 2 diabetes
Modern diets are high in advanced glycation end-products (dAGEs), derived from processing methods, exerting a pivotal role in promoting atherosclerotic risk. In this cross-sectional study we investigate the relationship between dAGE intake, arterial stiffness, inflammatory profile and macronutrient...
Saved in:
| Published in | Nutrition, metabolism, and cardiovascular diseases Vol. 27; no. 11; pp. 978 - 984 |
|---|---|
| Main Authors | , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Netherlands
Elsevier B.V
01.11.2017
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Modern diets are high in advanced glycation end-products (dAGEs), derived from processing methods, exerting a pivotal role in promoting atherosclerotic risk. In this cross-sectional study we investigate the relationship between dAGE intake, arterial stiffness, inflammatory profile and macronutrient composition, in subjects with type 2 diabetes without overt cardiovascular disease.
Arterial stiffness, carboxy-methyl-lysine, endogenous secretory receptor for AGEs (esRAGE), high sensitivity C reactive protein (hs-CRP), S100A12 and macronutrient intake were evaluated in 85 subjects with type 2 diabetes. The subjects were stratified into two groups according to dAGE consumption: high and low dAGE intake (≥ or <15.000 kU/day, respectively). Subjects with high dAGE intake (n = 45) showed a higher augmentation, augmentation index and pulse wave velocity (PWV) compared with those subjects with low dAGE intake (18 ± 5.4 vs 12.2 ± 6.3 mmHg, P < 0.05; 38.3 ± 5.4 vs 29.3 ± 10%; 9.2 ± 1.4 m/sec vs 7.9 ± 1.7, P < 0.05, respectively). hs-CRP were higher in subjects with high dAGE intake [0.42 (0.18–0.54) vs 0.21 (0.14–0.52) mg/dL, P < 0.05] whereas esRAGE plasma levels were lower [0.16 (0.23–0.81) vs 0.2 (0.14–0.54) ng/dL, P < 0.05]. Simple regression analysis showed a correlation between dAGEs and fat intake. Multivariate analysis showed an independent association between augmentation, systolic blood pressure (BP) and dAGE consumption; BMI and esRAGE were the major determinants of PWV.
Our data suggests that a chronic high dAGE diet could lead to a vascular dysfunction and inflammatory activation, contributing to the development of vascular complications in subjects with type 2 diabetes. Testing this hypothesis may represent a direction of future research.
•We studied dAGEs intake and cardiovascular risk in subjects with type 2 diabetes.•Subjects with high dAGEs intake had high arterial stiffness and inflammatory markers.•Arterial stiffness was independently associated with dAGEs in multivariate analysis.•Simple regression analysis evidenced a correlation between dAGEs and fat intake.•Subjects with diabetes and high dAGEs intake have increased cardiovascular risk. |
|---|---|
| AbstractList | Modern diets are high in advanced glycation end-products (dAGEs), derived from processing methods, exerting a pivotal role in promoting atherosclerotic risk. In this cross-sectional study we investigate the relationship between dAGE intake, arterial stiffness, inflammatory profile and macronutrient composition, in subjects with type 2 diabetes without overt cardiovascular disease.
Arterial stiffness, carboxy-methyl-lysine, endogenous secretory receptor for AGEs (esRAGE), high sensitivity C reactive protein (hs-CRP), S100A12 and macronutrient intake were evaluated in 85 subjects with type 2 diabetes. The subjects were stratified into two groups according to dAGE consumption: high and low dAGE intake (≥ or <15.000 kU/day, respectively). Subjects with high dAGE intake (n = 45) showed a higher augmentation, augmentation index and pulse wave velocity (PWV) compared with those subjects with low dAGE intake (18 ± 5.4 vs 12.2 ± 6.3 mmHg, P < 0.05; 38.3 ± 5.4 vs 29.3 ± 10%; 9.2 ± 1.4 m/sec vs 7.9 ± 1.7, P < 0.05, respectively). hs-CRP were higher in subjects with high dAGE intake [0.42 (0.18-0.54) vs 0.21 (0.14-0.52) mg/dL, P < 0.05] whereas esRAGE plasma levels were lower [0.16 (0.23-0.81) vs 0.2 (0.14-0.54) ng/dL, P < 0.05]. Simple regression analysis showed a correlation between dAGEs and fat intake. Multivariate analysis showed an independent association between augmentation, systolic blood pressure (BP) and dAGE consumption; BMI and esRAGE were the major determinants of PWV.
Our data suggests that a chronic high dAGE diet could lead to a vascular dysfunction and inflammatory activation, contributing to the development of vascular complications in subjects with type 2 diabetes. Testing this hypothesis may represent a direction of future research. Modern diets are high in advanced glycation end-products (dAGEs), derived from processing methods, exerting a pivotal role in promoting atherosclerotic risk. In this cross-sectional study we investigate the relationship between dAGE intake, arterial stiffness, inflammatory profile and macronutrient composition, in subjects with type 2 diabetes without overt cardiovascular disease. Arterial stiffness, carboxy-methyl-lysine, endogenous secretory receptor for AGEs (esRAGE), high sensitivity C reactive protein (hs-CRP), S100A12 and macronutrient intake were evaluated in 85 subjects with type 2 diabetes. The subjects were stratified into two groups according to dAGE consumption: high and low dAGE intake (≥ or <15.000 kU/day, respectively). Subjects with high dAGE intake (n = 45) showed a higher augmentation, augmentation index and pulse wave velocity (PWV) compared with those subjects with low dAGE intake (18 ± 5.4 vs 12.2 ± 6.3 mmHg, P < 0.05; 38.3 ± 5.4 vs 29.3 ± 10%; 9.2 ± 1.4 m/sec vs 7.9 ± 1.7, P < 0.05, respectively). hs-CRP were higher in subjects with high dAGE intake [0.42 (0.18–0.54) vs 0.21 (0.14–0.52) mg/dL, P < 0.05] whereas esRAGE plasma levels were lower [0.16 (0.23–0.81) vs 0.2 (0.14–0.54) ng/dL, P < 0.05]. Simple regression analysis showed a correlation between dAGEs and fat intake. Multivariate analysis showed an independent association between augmentation, systolic blood pressure (BP) and dAGE consumption; BMI and esRAGE were the major determinants of PWV. Our data suggests that a chronic high dAGE diet could lead to a vascular dysfunction and inflammatory activation, contributing to the development of vascular complications in subjects with type 2 diabetes. Testing this hypothesis may represent a direction of future research. •We studied dAGEs intake and cardiovascular risk in subjects with type 2 diabetes.•Subjects with high dAGEs intake had high arterial stiffness and inflammatory markers.•Arterial stiffness was independently associated with dAGEs in multivariate analysis.•Simple regression analysis evidenced a correlation between dAGEs and fat intake.•Subjects with diabetes and high dAGEs intake have increased cardiovascular risk. Modern diets are high in advanced glycation end-products (dAGEs), derived from processing methods, exerting a pivotal role in promoting atherosclerotic risk. In this cross-sectional study we investigate the relationship between dAGE intake, arterial stiffness, inflammatory profile and macronutrient composition, in subjects with type 2 diabetes without overt cardiovascular disease.Arterial stiffness, carboxy-methyl-lysine, endogenous secretory receptor for AGEs (esRAGE), high sensitivity C reactive protein (hs-CRP), S100A12 and macronutrient intake were evaluated in 85 subjects with type 2 diabetes. The subjects were stratified into two groups according to dAGE consumption: high and low dAGE intake (≥ or <15.000 kU/day, respectively). Subjects with high dAGE intake (n = 45) showed a higher augmentation, augmentation index and pulse wave velocity (PWV) compared with those subjects with low dAGE intake (18 ± 5.4 vs 12.2 ± 6.3 mmHg, P < 0.05; 38.3 ± 5.4 vs 29.3 ± 10%; 9.2 ± 1.4 m/sec vs 7.9 ± 1.7, P < 0.05, respectively). hs-CRP were higher in subjects with high dAGE intake [0.42 (0.18–0.54) vs 0.21 (0.14–0.52) mg/dL, P < 0.05] whereas esRAGE plasma levels were lower [0.16 (0.23–0.81) vs 0.2 (0.14–0.54) ng/dL, P < 0.05]. Simple regression analysis showed a correlation between dAGEs and fat intake. Multivariate analysis showed an independent association between augmentation, systolic blood pressure (BP) and dAGE consumption; BMI and esRAGE were the major determinants of PWV.Our data suggests that a chronic high dAGE diet could lead to a vascular dysfunction and inflammatory activation, contributing to the development of vascular complications in subjects with type 2 diabetes. Testing this hypothesis may represent a direction of future research. Modern diets are high in advanced glycation end-products (dAGEs), derived from processing methods, exerting a pivotal role in promoting atherosclerotic risk. In this cross-sectional study we investigate the relationship between dAGE intake, arterial stiffness, inflammatory profile and macronutrient composition, in subjects with type 2 diabetes without overt cardiovascular disease.BACKGROUND AND AIMSModern diets are high in advanced glycation end-products (dAGEs), derived from processing methods, exerting a pivotal role in promoting atherosclerotic risk. In this cross-sectional study we investigate the relationship between dAGE intake, arterial stiffness, inflammatory profile and macronutrient composition, in subjects with type 2 diabetes without overt cardiovascular disease.Arterial stiffness, carboxy-methyl-lysine, endogenous secretory receptor for AGEs (esRAGE), high sensitivity C reactive protein (hs-CRP), S100A12 and macronutrient intake were evaluated in 85 subjects with type 2 diabetes. The subjects were stratified into two groups according to dAGE consumption: high and low dAGE intake (≥ or <15.000 kU/day, respectively). Subjects with high dAGE intake (n = 45) showed a higher augmentation, augmentation index and pulse wave velocity (PWV) compared with those subjects with low dAGE intake (18 ± 5.4 vs 12.2 ± 6.3 mmHg, P < 0.05; 38.3 ± 5.4 vs 29.3 ± 10%; 9.2 ± 1.4 m/sec vs 7.9 ± 1.7, P < 0.05, respectively). hs-CRP were higher in subjects with high dAGE intake [0.42 (0.18-0.54) vs 0.21 (0.14-0.52) mg/dL, P < 0.05] whereas esRAGE plasma levels were lower [0.16 (0.23-0.81) vs 0.2 (0.14-0.54) ng/dL, P < 0.05]. Simple regression analysis showed a correlation between dAGEs and fat intake. Multivariate analysis showed an independent association between augmentation, systolic blood pressure (BP) and dAGE consumption; BMI and esRAGE were the major determinants of PWV.METHODS AND RESULTSArterial stiffness, carboxy-methyl-lysine, endogenous secretory receptor for AGEs (esRAGE), high sensitivity C reactive protein (hs-CRP), S100A12 and macronutrient intake were evaluated in 85 subjects with type 2 diabetes. The subjects were stratified into two groups according to dAGE consumption: high and low dAGE intake (≥ or <15.000 kU/day, respectively). Subjects with high dAGE intake (n = 45) showed a higher augmentation, augmentation index and pulse wave velocity (PWV) compared with those subjects with low dAGE intake (18 ± 5.4 vs 12.2 ± 6.3 mmHg, P < 0.05; 38.3 ± 5.4 vs 29.3 ± 10%; 9.2 ± 1.4 m/sec vs 7.9 ± 1.7, P < 0.05, respectively). hs-CRP were higher in subjects with high dAGE intake [0.42 (0.18-0.54) vs 0.21 (0.14-0.52) mg/dL, P < 0.05] whereas esRAGE plasma levels were lower [0.16 (0.23-0.81) vs 0.2 (0.14-0.54) ng/dL, P < 0.05]. Simple regression analysis showed a correlation between dAGEs and fat intake. Multivariate analysis showed an independent association between augmentation, systolic blood pressure (BP) and dAGE consumption; BMI and esRAGE were the major determinants of PWV.Our data suggests that a chronic high dAGE diet could lead to a vascular dysfunction and inflammatory activation, contributing to the development of vascular complications in subjects with type 2 diabetes. Testing this hypothesis may represent a direction of future research.CONCLUSIONSOur data suggests that a chronic high dAGE diet could lead to a vascular dysfunction and inflammatory activation, contributing to the development of vascular complications in subjects with type 2 diabetes. Testing this hypothesis may represent a direction of future research. |
| Author | Piro, S. Purrello, F. Scicali, R. Rabuazzo, A.M. Di Pino, A. Urbano, F. Currenti, W. |
| Author_xml | – sequence: 1 givenname: A. surname: Di Pino fullname: Di Pino, A. – sequence: 2 givenname: W. surname: Currenti fullname: Currenti, W. – sequence: 3 givenname: F. surname: Urbano fullname: Urbano, F. – sequence: 4 givenname: R. surname: Scicali fullname: Scicali, R. – sequence: 5 givenname: S. surname: Piro fullname: Piro, S. – sequence: 6 givenname: F. surname: Purrello fullname: Purrello, F. email: fpurrell@unict.it – sequence: 7 givenname: A.M. surname: Rabuazzo fullname: Rabuazzo, A.M. |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28958695$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkcFu1DAURS1URKeFP0DISzZJbSd2YoSQqgooUiU2sLYc-7l4mjiD7RTNn_C5OJ2WRTeTjRXp3CP73jN0EuYACL2lpKaEiottHZYJjK0ZoV1NRE1o-wJtKJekajomT9CGyEZWbcebU3SW0paQpiNN-wqdsl7yXki-QX-v_e0v7EPWd4Bnh62HrOMea3uvgwGLb8e90dnPAUOw1S7OdjE5YZ-wTmk2XucC_fF5lZgIOpVfHTNEr0ecsncuQCpwsAVwo56mg80HnJZhC6vsIZ73O8CsXEAPkCG9Ri-dHhO8eTzP0c8vn39cXVc3379-u7q8qUzb9rliTUOYHITTnbDcOcFla8RgBHeaU0p5b7uWDla7DnpmrWkLyhmXxgowtG_O0fuDtzzt9wIpq8knA-OoA8xLUow2tO8EadhRlMqWM9qVr6DvHtFlmMCqXfRTqVU9FV-A9gCYOKcUwf1HKFHrvmqrDvuqdV9FhCr7ltiHZzHj80OhOWo_Hgt_OoSh9HnvIapkPKwr-1h2UHb2xwQfnwnM6IM3eryD_fH4P5oO2rU |
| CitedBy_id | crossref_primary_10_1039_C9FO00240E crossref_primary_10_1093_ajcn_nqaa117 crossref_primary_10_1093_nutrit_nuac090 crossref_primary_10_1016_j_gene_2019_04_084 crossref_primary_10_1186_s12933_023_01979_1 crossref_primary_10_1016_j_foodres_2023_113901 crossref_primary_10_3390_nu14122421 crossref_primary_10_1590_2175_8239_jbn_2022_0006pt crossref_primary_10_1007_s40619_019_00575_4 crossref_primary_10_1016_j_foodres_2021_110839 crossref_primary_10_1016_j_lwt_2018_03_023 crossref_primary_10_3390_nu13124435 crossref_primary_10_1016_j_biopha_2017_10_085 crossref_primary_10_3389_fnut_2022_1076723 crossref_primary_10_1016_j_ijbiomac_2018_12_011 crossref_primary_10_1186_s12902_019_0420_1 crossref_primary_10_3390_ijerph20053788 crossref_primary_10_1002_mnfr_202200046 crossref_primary_10_1007_s00592_018_1144_9 crossref_primary_10_1093_nutrit_nuad099 crossref_primary_10_1053_j_jrn_2018_08_007 crossref_primary_10_1186_s12902_022_00997_6 crossref_primary_10_4239_wjd_v14_i7_995 crossref_primary_10_1097_MOL_0000000000000452 crossref_primary_10_1177_1479164120953626 crossref_primary_10_1007_s12640_018_9867_5 crossref_primary_10_3390_ijms21124567 crossref_primary_10_1016_j_foodchem_2024_138930 crossref_primary_10_1007_s00592_019_01338_1 crossref_primary_10_1007_s12012_021_09697_4 crossref_primary_10_1016_j_amjcard_2022_10_006 crossref_primary_10_1590_2175_8239_jbn_2022_0006en crossref_primary_10_1111_jfpe_14208 crossref_primary_10_1016_j_jdiacomp_2022_108354 crossref_primary_10_3389_fcvm_2021_709396 crossref_primary_10_33590_emjdiabet_10312768 crossref_primary_10_3390_math11071645 crossref_primary_10_3390_nu14020371 crossref_primary_10_1016_j_envint_2018_12_032 crossref_primary_10_1111_nbu_12653 crossref_primary_10_1002_dmrr_3367 crossref_primary_10_3233_CH_180486 crossref_primary_10_1016_j_jad_2024_02_040 crossref_primary_10_1186_s12933_020_01068_7 crossref_primary_10_1093_jn_nxab097 crossref_primary_10_12677_acm_2024_1441079 crossref_primary_10_1016_j_numecd_2021_09_005 crossref_primary_10_1016_j_lwt_2022_113161 crossref_primary_10_1016_j_jsbmb_2021_106042 crossref_primary_10_1161_ATVBAHA_119_313880 crossref_primary_10_1093_nutrit_nuab095 crossref_primary_10_1016_j_phrs_2021_105602 crossref_primary_10_1038_s41598_019_56857_2 crossref_primary_10_1186_s12902_020_00548_x crossref_primary_10_1016_j_molliq_2018_02_059 crossref_primary_10_1016_j_hlc_2021_06_527 crossref_primary_10_1016_j_numecd_2021_05_011 crossref_primary_10_1016_j_foodchem_2023_136111 crossref_primary_10_1016_j_pbb_2019_172743 crossref_primary_10_1016_j_jmbbm_2023_106198 crossref_primary_10_3390_nu12061767 crossref_primary_10_1016_j_numecd_2021_08_030 crossref_primary_10_3390_nu14112273 crossref_primary_10_1016_j_ijbiomac_2019_09_118 crossref_primary_10_1093_nutrit_nuab020 |
| Cites_doi | 10.1007/s12020-015-0805-5 10.1017/S0029665112003023 10.1016/j.jacl.2016.07.001 10.1161/01.ATV.0000190660.32863.cd 10.1093/jn/117.9.1638 10.1530/EJE-11-0765 10.1016/j.jada.2010.03.018 10.1210/jc.2005-2559 10.1051/jbio:2007022 10.2337/dc13-2357 10.1007/s00125-007-0759-0 10.1073/pnas.242407999 10.1161/01.ATV.0000158380.44231.fe 10.1161/CIRCULATIONAHA.106.621854 10.1017/S0007114515003487 10.2337/diabetes.54.8.2314 10.2337/diabetes.51.7.2082 10.1371/journal.pone.0085202 10.1056/NEJM199807233390404 10.1016/S0272-6386(03)00779-0 10.2337/db12-1528 10.1016/j.nut.2014.10.004 10.1093/gerona/62.4.427 10.1016/j.jada.2004.05.214 10.1155/2015/846807 10.1210/jc.2015-4069 10.1093/ajcn/85.5.1236 10.1016/j.atherosclerosis.2015.09.038 |
| ContentType | Journal Article |
| Copyright | 2017 The Italian Society of Diabetology, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition, and the Department of Clinical Medicine and Surgery, Federico II University Copyright © 2017 The Italian Society of Diabetology, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition, and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved. |
| Copyright_xml | – notice: 2017 The Italian Society of Diabetology, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition, and the Department of Clinical Medicine and Surgery, Federico II University – notice: Copyright © 2017 The Italian Society of Diabetology, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition, and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 7S9 L.6 |
| DOI | 10.1016/j.numecd.2017.06.014 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
| DatabaseTitleList | MEDLINE AGRICOLA MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1590-3729 |
| EndPage | 984 |
| ExternalDocumentID | 28958695 10_1016_j_numecd_2017_06_014 S0939475317301357 |
| Genre | Journal Article |
| GroupedDBID | --- --K --M .1- .FO .GJ .~1 0R~ 123 1B1 1P~ 1~. 1~5 29N 4.4 457 4G. 53G 5VS 7-5 71M 8P~ AAEDT AAEDW AAFWJ AAHBH AAIKJ AAKOC AALRI AAOAW AAQFI AATTM AAWTL AAXKI AAXUO AAYWO ABBQC ABFNM ABMAC ABMZM ABWVN ABXDB ACDAQ ACGFS ACIEU ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADMUD ADNMO AEBSH AEIPS AEKER AENEX AEUPX AEVXI AFJKZ AFPUW AFRHN AFTJW AFXIZ AGCQF AGHFR AGUBO AGYEJ AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX AXJTR BKOJK BLXMC BNPGV CS3 DU5 EBS EFJIC EFKBS EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FIRID FNPLU FYGXN G-Q GBLVA HVGLF HZ~ IHE J1W KOM M41 MO0 N9A O-L O9- OAUVE OA~ OL0 OZT P-8 P-9 P2P PC. Q38 ROL RPZ SDF SDG SDH SEL SES SEW SSH SSZ T5K Z5R ~G- AACTN AAIAV ABLVK ABYKQ AFCTW AFKWA AJBFU AJOXV AMFUW EFLBG LCYCR RIG ZA5 AAYXX AGRNS CITATION CGR CUY CVF ECM EIF NPM 7X8 7S9 L.6 |
| ID | FETCH-LOGICAL-c448t-233029b6fa76d5ff6594c6bc65fa511158d741bdaf7e82ddc46fa5259cd6ec183 |
| IEDL.DBID | .~1 |
| ISSN | 0939-4753 1590-3729 |
| IngestDate | Fri Jul 11 06:06:56 EDT 2025 Fri Jul 11 12:04:36 EDT 2025 Wed Feb 19 02:41:51 EST 2025 Tue Jul 01 04:30:56 EDT 2025 Thu Apr 24 23:11:29 EDT 2025 Fri Feb 23 02:31:58 EST 2024 Tue Aug 26 16:32:30 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 11 |
| Keywords | Type 2 diabetes Dietary advanced glycation end-products Cardiovascular disease Inflammation Soluble receptor for advanced glycation endproducts |
| Language | English |
| License | Copyright © 2017 The Italian Society of Diabetology, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition, and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c448t-233029b6fa76d5ff6594c6bc65fa511158d741bdaf7e82ddc46fa5259cd6ec183 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| PMID | 28958695 |
| PQID | 1945217777 |
| PQPubID | 23479 |
| PageCount | 7 |
| ParticipantIDs | proquest_miscellaneous_2131876032 proquest_miscellaneous_1945217777 pubmed_primary_28958695 crossref_primary_10_1016_j_numecd_2017_06_014 crossref_citationtrail_10_1016_j_numecd_2017_06_014 elsevier_sciencedirect_doi_10_1016_j_numecd_2017_06_014 elsevier_clinicalkey_doi_10_1016_j_numecd_2017_06_014 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | November 2017 2017-11-00 2017-Nov 20171101 |
| PublicationDateYYYYMMDD | 2017-11-01 |
| PublicationDate_xml | – month: 11 year: 2017 text: November 2017 |
| PublicationDecade | 2010 |
| PublicationPlace | Netherlands |
| PublicationPlace_xml | – name: Netherlands |
| PublicationTitle | Nutrition, metabolism, and cardiovascular diseases |
| PublicationTitleAlternate | Nutr Metab Cardiovasc Dis |
| PublicationYear | 2017 |
| Publisher | Elsevier B.V |
| Publisher_xml | – name: Elsevier B.V |
| References | Zagami, Di Pino, Urbano, Piro, Purrello, Rabuazzo (bib18) 2015 Haffner, Lehto, Rönnemaa, Pyörälä, Laakso (bib1) 1998; 339 Di Pino, Urbano, Zagami, Filippello, Di Mauro, Piro (bib9) 2016; 101 Grossin, Wautier (bib20) 2007; 201 Chilelli, Cremasco, Cosma, Ragazzi, Francini Pesenti, Bonfante (bib27) 2016; 54 Goldin, Beckman, Schmidt, Creager (bib6) 2006; 114 Trial, Semba, Gebauer, Baer, Sun, Turner (bib23) 2014 Selvin, Halushka, Rawlings, Hoogeveen, Ballantyne, Coresh (bib10) 2013; 62 Tan, Chow, Tso, Xu, Tse, Hoo (bib22) 2007; 50 Uribarri, Woodruff, Goodman, Cai, Chen, Pyzik (bib7) 2010; 110 Macías-Cervantes, Rodríguez-Soto, Uribarri, Díaz-Cisneros, Cai, Garay-Sevilla (bib15) 2015; 31 Sandu, Song, Cai, Zheng, Uribarri, Vlassara (bib11) 2005; 54 (bib14) 2016; 39 Di Pino, Scicali, Calanna, Urbano, Mantegna, Rabuazzo (bib17) 2014; 37 Davis, Prasad, Vijayagopal, Juma, Adams-Huet, Imrhan (bib29) 2015; 114 Goldberg, Cai, Peppa, Dardaine, Baliga, Uribarri (bib4) 2004; 104 Uribarri, Peppa, Cai, Goldberg, Lu, Baliga (bib28) 2003; 42 Koyama, Shoji, Yokoyama, Motoyama, Mori, Fukumoto (bib24) 2005; 25 Vlassara, Cai, Crandall, Goldberg, Oberstein, Dardaine (bib26) 2002; 99 Mathers (bib3) 2013; 72 Basta, Sironi, Lazzerini, Del Turco, Buzzigoli, Casolaro (bib8) 2006; 91 Hofmann, Dong, Li, Cai, Altomonte, Thung (bib12) 2002; 51 Di Pino, Currenti, Urbano, Mantegna, Purrazzo, Piro (bib13) 2016 Mayneris-Perxachs, Sala-Vila, Chisaguano, Castellote, Estruch, Covas (bib2) 2014; 9 Calanna, Urbano, Piro, Zagami, Di Pino, Spadaro (bib16) 2012; 166 Uribarri, Cai, Melpomeni, Goodman, Ferrucci, Striker (bib25) 2007 April; 62 Basiotis, Welsh, Cronin, Kelsay, Mertz (bib30) 1987; 117 Negrean, Stirban, Stratmann, Gawlowski, Horstmann, Götting (bib21) 2007; 85 Kilhovd, Juutilainen, Lehto, Rönnemaa, Torjesen, Birkeland (bib5) 2005; 25 Davenport, Ashley, O'Sullivan, McHenry, Agha, Thompson (bib19) 2015; 2015 Tan (10.1016/j.numecd.2017.06.014_bib22) 2007; 50 Basiotis (10.1016/j.numecd.2017.06.014_bib30) 1987; 117 Vlassara (10.1016/j.numecd.2017.06.014_bib26) 2002; 99 Haffner (10.1016/j.numecd.2017.06.014_bib1) 1998; 339 Davis (10.1016/j.numecd.2017.06.014_bib29) 2015; 114 Zagami (10.1016/j.numecd.2017.06.014_bib18) 2015 Davenport (10.1016/j.numecd.2017.06.014_bib19) 2015; 2015 Sandu (10.1016/j.numecd.2017.06.014_bib11) 2005; 54 Di Pino (10.1016/j.numecd.2017.06.014_bib13) 2016 Mathers (10.1016/j.numecd.2017.06.014_bib3) 2013; 72 Trial (10.1016/j.numecd.2017.06.014_bib23) 2014 Selvin (10.1016/j.numecd.2017.06.014_bib10) 2013; 62 Calanna (10.1016/j.numecd.2017.06.014_bib16) 2012; 166 Chilelli (10.1016/j.numecd.2017.06.014_bib27) 2016; 54 Negrean (10.1016/j.numecd.2017.06.014_bib21) 2007; 85 (10.1016/j.numecd.2017.06.014_bib14) 2016; 39 Goldin (10.1016/j.numecd.2017.06.014_bib6) 2006; 114 Uribarri (10.1016/j.numecd.2017.06.014_bib25) 2007; 62 Mayneris-Perxachs (10.1016/j.numecd.2017.06.014_bib2) 2014; 9 Grossin (10.1016/j.numecd.2017.06.014_bib20) 2007; 201 Uribarri (10.1016/j.numecd.2017.06.014_bib28) 2003; 42 Uribarri (10.1016/j.numecd.2017.06.014_bib7) 2010; 110 Hofmann (10.1016/j.numecd.2017.06.014_bib12) 2002; 51 Kilhovd (10.1016/j.numecd.2017.06.014_bib5) 2005; 25 Di Pino (10.1016/j.numecd.2017.06.014_bib17) 2014; 37 Koyama (10.1016/j.numecd.2017.06.014_bib24) 2005; 25 Basta (10.1016/j.numecd.2017.06.014_bib8) 2006; 91 Di Pino (10.1016/j.numecd.2017.06.014_bib9) 2016; 101 Goldberg (10.1016/j.numecd.2017.06.014_bib4) 2004; 104 Macías-Cervantes (10.1016/j.numecd.2017.06.014_bib15) 2015; 31 |
| References_xml | – volume: 25 start-page: 815 year: 2005 end-page: 820 ident: bib5 article-title: High serum levels of advanced glycation end products predict increased coronary heart disease mortality in nondiabetic women but not in nondiabetic men: a population-based 18-year follow-up study publication-title: Arterioscler Thromb Vasc Biol – volume: 25 start-page: 2587 year: 2005 end-page: 2593 ident: bib24 article-title: Plasma level of endogenous secretory RAGE is associated with components of the metabolic syndrome and atherosclerosis publication-title: Arterioscler Thromb Vasc Biol – year: 2016 ident: bib13 article-title: Low advanced glycation end product diet improves the lipid and inflammatory profiles of prediabetic subjects publication-title: J Clin Lipidol – volume: 99 start-page: 15596 year: 2002 end-page: 15601 ident: bib26 article-title: Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy publication-title: Proc Natl Acad Sci USA – volume: 166 start-page: 917 year: 2012 end-page: 922 ident: bib16 article-title: Elevated plasma glucose-dependent insulinotropic polypeptide associates with hyperinsulinemia in metabolic syndrome publication-title: Eur J Endocrinol – volume: 2015 year: 2015 ident: bib19 article-title: The effects of atorvastatin on arterial stiffness in male patients with type 2 diabetes publication-title: J Diabetes Res – volume: 339 start-page: 229 year: 1998 end-page: 234 ident: bib1 article-title: Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction publication-title: N Engl J Med – volume: 50 start-page: 1819 year: 2007 end-page: 1825 ident: bib22 article-title: Thiazolidinedione increases serum soluble receptor for advanced glycation end-products in type 2 diabetes publication-title: Diabetologia – volume: 42 start-page: 532 year: 2003 end-page: 538 ident: bib28 article-title: Dietary glycotoxins correlate with circulating advanced glycation end product levels in renal failure patients publication-title: Am J Kidney Dis – volume: 101 start-page: 1701 year: 2016 end-page: 1709 ident: bib9 article-title: Low endogenous secretory receptor for advanced glycation end-products levels are associated with inflammation and carotid atherosclerosis in prediabetes publication-title: J Clin Endocrinol Metab – volume: 39 start-page: S522 year: 2016 end-page: S559 ident: bib14 article-title: Standards of medical care in diabetes-2016 publication-title: Diabetes Care – volume: 85 start-page: 1236 year: 2007 end-page: 1243 ident: bib21 article-title: Effects of low- and high-advanced glycation end product meals on macro- and microvascular endothelial function and oxidative stress in patients with type 2 diabetes mellitus publication-title: Am J Clin Nutr – volume: 51 start-page: 2082 year: 2002 end-page: 2089 ident: bib12 article-title: Improved insulin sensitivity is associated with restricted intake of dietary glycoxidation products in the db/db mouse publication-title: Diabetes – volume: 31 start-page: 446 year: 2015 end-page: 451 ident: bib15 article-title: Effect of an advanced glycation end product-restricted diet and exercise on metabolic parameters in adult overweight men publication-title: Nutrition – volume: 54 start-page: 2314 year: 2005 end-page: 2319 ident: bib11 article-title: Insulin resistance and type 2 diabetes in high-fat-fed mice are linked to high glycotoxin intake publication-title: Diabetes – volume: 62 start-page: 427 year: 2007 April end-page: 433 ident: bib25 article-title: Circulating glycotoxins and dietary advanced glycation endproducts: two links to inflammatory response, oxidative stress, and aging publication-title: J Gerontol A Biol Sci Med Sci. – volume: 91 start-page: 4628 year: 2006 end-page: 4634 ident: bib8 article-title: Circulating soluble receptor for advanced glycation end products is inversely associated with glycemic control and S100A12 protein publication-title: J Clin Endocrinol Metab – year: 2015 ident: bib18 article-title: Low circulating Vitamin D levels are associated with increased arterial stiffness in prediabetic subjects identified according to HbA1c publication-title: Atherosclerosis – start-page: 1037 year: 2014 end-page: 1042 ident: bib23 article-title: Dietary intake of advanced glycation end products did not affect endothelial function and inflammation in healthy adults in a randomized controlled trial publication-title: J Nutr – volume: 114 start-page: 597 year: 2006 end-page: 605 ident: bib6 article-title: Advanced glycation end products: sparking the development of diabetic vascular injury publication-title: Circulation – volume: 72 start-page: 246 year: 2013 end-page: 250 ident: bib3 article-title: Nutrition and ageing: knowledge, gaps and research priorities publication-title: Proc Nutr Soc – volume: 201 start-page: 175 year: 2007 end-page: 184 ident: bib20 article-title: Protein glycation and endothelium dysfunction publication-title: J Soc Biol – volume: 37 start-page: 1447 year: 2014 end-page: 1453 ident: bib17 article-title: Cardiovascular risk profile in subjects with prediabetes and new-onset type 2 diabetes identified by HbA(1c) according to American Diabetes Association criteria publication-title: Diabetes Care – volume: 104 start-page: 1287 year: 2004 end-page: 1291 ident: bib4 article-title: Advanced glycoxidation end products in commonly consumed foods publication-title: J Am Diet Assoc – volume: 110 start-page: 911 year: 2010 end-page: 916.e12 ident: bib7 article-title: Advanced glycation end products in foods and a practical guide to their reduction in the diet publication-title: J Am Diet Assoc – volume: 114 start-page: 1797 year: 2015 end-page: 1806 ident: bib29 article-title: Contribution of dietary advanced glycation end products (AGE) to circulating AGE: role of dietary fat publication-title: Br J Nutr – volume: 117 start-page: 1638 year: 1987 end-page: 1641 ident: bib30 article-title: Number of days of food intake records required to estimate individual and group nutrient intakes with defined confidence publication-title: J Nutr – volume: 62 start-page: 2116 year: 2013 end-page: 2121 ident: bib10 article-title: sRAGE and risk of diabetes, cardiovascular disease, and death publication-title: Diabetes – volume: 9 start-page: e85202 year: 2014 ident: bib2 article-title: Effects of 1-year intervention with a Mediterranean diet on plasma fatty acid composition and metabolic syndrome in a population at high cardiovascular risk publication-title: PLoS One – volume: 54 start-page: 552 year: 2016 end-page: 555 ident: bib27 article-title: Effectiveness of a diet with low advanced glycation end products, in improving glycoxidation and lipid peroxidation: a long-term investigation in patients with chronic renal failure publication-title: Endocrine – volume: 54 start-page: 552 year: 2016 ident: 10.1016/j.numecd.2017.06.014_bib27 article-title: Effectiveness of a diet with low advanced glycation end products, in improving glycoxidation and lipid peroxidation: a long-term investigation in patients with chronic renal failure publication-title: Endocrine doi: 10.1007/s12020-015-0805-5 – volume: 72 start-page: 246 year: 2013 ident: 10.1016/j.numecd.2017.06.014_bib3 article-title: Nutrition and ageing: knowledge, gaps and research priorities publication-title: Proc Nutr Soc doi: 10.1017/S0029665112003023 – year: 2016 ident: 10.1016/j.numecd.2017.06.014_bib13 article-title: Low advanced glycation end product diet improves the lipid and inflammatory profiles of prediabetic subjects publication-title: J Clin Lipidol doi: 10.1016/j.jacl.2016.07.001 – volume: 25 start-page: 2587 year: 2005 ident: 10.1016/j.numecd.2017.06.014_bib24 article-title: Plasma level of endogenous secretory RAGE is associated with components of the metabolic syndrome and atherosclerosis publication-title: Arterioscler Thromb Vasc Biol doi: 10.1161/01.ATV.0000190660.32863.cd – volume: 117 start-page: 1638 year: 1987 ident: 10.1016/j.numecd.2017.06.014_bib30 article-title: Number of days of food intake records required to estimate individual and group nutrient intakes with defined confidence publication-title: J Nutr doi: 10.1093/jn/117.9.1638 – volume: 166 start-page: 917 year: 2012 ident: 10.1016/j.numecd.2017.06.014_bib16 article-title: Elevated plasma glucose-dependent insulinotropic polypeptide associates with hyperinsulinemia in metabolic syndrome publication-title: Eur J Endocrinol doi: 10.1530/EJE-11-0765 – volume: 110 start-page: 911 year: 2010 ident: 10.1016/j.numecd.2017.06.014_bib7 article-title: Advanced glycation end products in foods and a practical guide to their reduction in the diet publication-title: J Am Diet Assoc doi: 10.1016/j.jada.2010.03.018 – volume: 91 start-page: 4628 year: 2006 ident: 10.1016/j.numecd.2017.06.014_bib8 article-title: Circulating soluble receptor for advanced glycation end products is inversely associated with glycemic control and S100A12 protein publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2005-2559 – volume: 201 start-page: 175 year: 2007 ident: 10.1016/j.numecd.2017.06.014_bib20 article-title: Protein glycation and endothelium dysfunction publication-title: J Soc Biol doi: 10.1051/jbio:2007022 – volume: 39 start-page: S522 issue: Suppl. 1 year: 2016 ident: 10.1016/j.numecd.2017.06.014_bib14 article-title: Standards of medical care in diabetes-2016 publication-title: Diabetes Care – volume: 37 start-page: 1447 year: 2014 ident: 10.1016/j.numecd.2017.06.014_bib17 article-title: Cardiovascular risk profile in subjects with prediabetes and new-onset type 2 diabetes identified by HbA(1c) according to American Diabetes Association criteria publication-title: Diabetes Care doi: 10.2337/dc13-2357 – volume: 50 start-page: 1819 year: 2007 ident: 10.1016/j.numecd.2017.06.014_bib22 article-title: Thiazolidinedione increases serum soluble receptor for advanced glycation end-products in type 2 diabetes publication-title: Diabetologia doi: 10.1007/s00125-007-0759-0 – volume: 99 start-page: 15596 year: 2002 ident: 10.1016/j.numecd.2017.06.014_bib26 article-title: Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.242407999 – volume: 25 start-page: 815 year: 2005 ident: 10.1016/j.numecd.2017.06.014_bib5 article-title: High serum levels of advanced glycation end products predict increased coronary heart disease mortality in nondiabetic women but not in nondiabetic men: a population-based 18-year follow-up study publication-title: Arterioscler Thromb Vasc Biol doi: 10.1161/01.ATV.0000158380.44231.fe – volume: 114 start-page: 597 year: 2006 ident: 10.1016/j.numecd.2017.06.014_bib6 article-title: Advanced glycation end products: sparking the development of diabetic vascular injury publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.106.621854 – volume: 114 start-page: 1797 year: 2015 ident: 10.1016/j.numecd.2017.06.014_bib29 article-title: Contribution of dietary advanced glycation end products (AGE) to circulating AGE: role of dietary fat publication-title: Br J Nutr doi: 10.1017/S0007114515003487 – volume: 54 start-page: 2314 year: 2005 ident: 10.1016/j.numecd.2017.06.014_bib11 article-title: Insulin resistance and type 2 diabetes in high-fat-fed mice are linked to high glycotoxin intake publication-title: Diabetes doi: 10.2337/diabetes.54.8.2314 – volume: 51 start-page: 2082 year: 2002 ident: 10.1016/j.numecd.2017.06.014_bib12 article-title: Improved insulin sensitivity is associated with restricted intake of dietary glycoxidation products in the db/db mouse publication-title: Diabetes doi: 10.2337/diabetes.51.7.2082 – volume: 9 start-page: e85202 year: 2014 ident: 10.1016/j.numecd.2017.06.014_bib2 article-title: Effects of 1-year intervention with a Mediterranean diet on plasma fatty acid composition and metabolic syndrome in a population at high cardiovascular risk publication-title: PLoS One doi: 10.1371/journal.pone.0085202 – volume: 339 start-page: 229 year: 1998 ident: 10.1016/j.numecd.2017.06.014_bib1 article-title: Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction publication-title: N Engl J Med doi: 10.1056/NEJM199807233390404 – volume: 42 start-page: 532 year: 2003 ident: 10.1016/j.numecd.2017.06.014_bib28 article-title: Dietary glycotoxins correlate with circulating advanced glycation end product levels in renal failure patients publication-title: Am J Kidney Dis doi: 10.1016/S0272-6386(03)00779-0 – volume: 62 start-page: 2116 year: 2013 ident: 10.1016/j.numecd.2017.06.014_bib10 article-title: sRAGE and risk of diabetes, cardiovascular disease, and death publication-title: Diabetes doi: 10.2337/db12-1528 – volume: 31 start-page: 446 year: 2015 ident: 10.1016/j.numecd.2017.06.014_bib15 article-title: Effect of an advanced glycation end product-restricted diet and exercise on metabolic parameters in adult overweight men publication-title: Nutrition doi: 10.1016/j.nut.2014.10.004 – volume: 62 start-page: 427 issue: 4 year: 2007 ident: 10.1016/j.numecd.2017.06.014_bib25 article-title: Circulating glycotoxins and dietary advanced glycation endproducts: two links to inflammatory response, oxidative stress, and aging publication-title: J Gerontol A Biol Sci Med Sci. doi: 10.1093/gerona/62.4.427 – volume: 104 start-page: 1287 year: 2004 ident: 10.1016/j.numecd.2017.06.014_bib4 article-title: Advanced glycoxidation end products in commonly consumed foods publication-title: J Am Diet Assoc doi: 10.1016/j.jada.2004.05.214 – volume: 2015 year: 2015 ident: 10.1016/j.numecd.2017.06.014_bib19 article-title: The effects of atorvastatin on arterial stiffness in male patients with type 2 diabetes publication-title: J Diabetes Res doi: 10.1155/2015/846807 – volume: 101 start-page: 1701 year: 2016 ident: 10.1016/j.numecd.2017.06.014_bib9 article-title: Low endogenous secretory receptor for advanced glycation end-products levels are associated with inflammation and carotid atherosclerosis in prediabetes publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2015-4069 – volume: 85 start-page: 1236 year: 2007 ident: 10.1016/j.numecd.2017.06.014_bib21 article-title: Effects of low- and high-advanced glycation end product meals on macro- and microvascular endothelial function and oxidative stress in patients with type 2 diabetes mellitus publication-title: Am J Clin Nutr doi: 10.1093/ajcn/85.5.1236 – start-page: 1037 year: 2014 ident: 10.1016/j.numecd.2017.06.014_bib23 article-title: Dietary intake of advanced glycation end products did not affect endothelial function and inflammation in healthy adults in a randomized controlled trial publication-title: J Nutr – year: 2015 ident: 10.1016/j.numecd.2017.06.014_bib18 article-title: Low circulating Vitamin D levels are associated with increased arterial stiffness in prediabetic subjects identified according to HbA1c publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2015.09.038 |
| SSID | ssj0037034 |
| Score | 2.4193654 |
| Snippet | Modern diets are high in advanced glycation end-products (dAGEs), derived from processing methods, exerting a pivotal role in promoting atherosclerotic risk.... |
| SourceID | proquest pubmed crossref elsevier |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 978 |
| SubjectTerms | Adult advanced glycation end products Aged Biomarkers - blood body mass index C-Reactive Protein - analysis Cardiovascular disease cardiovascular diseases Carotid Intima-Media Thickness Cross-Sectional Studies Diabetes Mellitus, Type 2 - blood Diabetes Mellitus, Type 2 - complications Diabetes Mellitus, Type 2 - diagnosis Diabetic Angiopathies - blood Diabetic Angiopathies - diagnosis Diabetic Angiopathies - etiology Diabetic Angiopathies - physiopathology diet Diet - adverse effects Dietary advanced glycation end-products fat intake Female Glycation End Products, Advanced - administration & dosage Glycation End Products, Advanced - adverse effects Humans Inflammation Inflammation - blood Inflammation - diagnosis Inflammation - etiology Male metabolism Middle Aged noninsulin-dependent diabetes mellitus nutrition risk assessment processing technology Pulse Wave Analysis Receptor for Advanced Glycation End Products - blood regression analysis Risk Assessment Risk Factors Soluble receptor for advanced glycation endproducts systolic blood pressure Type 2 diabetes Vascular Stiffness |
| Title | High intake of dietary advanced glycation end-products is associated with increased arterial stiffness and inflammation in subjects with type 2 diabetes |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0939475317301357 https://dx.doi.org/10.1016/j.numecd.2017.06.014 https://www.ncbi.nlm.nih.gov/pubmed/28958695 https://www.proquest.com/docview/1945217777 https://www.proquest.com/docview/2131876032 |
| Volume | 27 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEBYhhdJL6bvbtEGFXt21rIdXx7A0bF-htA3kZvQsboN3ib2HXPI7-nM7Y1kLPSwp9cXIzBjb-jT6NJoZE_ImVtwDkTCFLy0vhC1toWupC6OrqBUAgJkxyvdMrc7Fhwt5cUCWORcGwyon259s-mitpyvz6WvON207_wZrcS2AbTMEKZeYUS5EjSh_e7ML8-CA6LGElMYdT5DO6XNjjFcH499hvVBWj1U8mdg3Pe2jn-M0dPqA3J_4Iz1Jj_iQHITuEbn7edohf0x-Y-AGbbvB_Ap0Halvw2Curmne66c_Lq-Tl46GzhebVPC1p21PzdRTIITeWbgJMsoemmPcJwCVgj2IEY0jNZ0HgQh4SrmP0KD91qJXp0_q6NylFc3O3Sfk_PTd9-WqmP6-UDhYsg1FxXlZaauiqZWXMSqphVPWKRkNsDQmFx7YiPUm1mFRee8EiEpYTTmvggNL8ZQcdusuPCfUlDxYJ4IJFovRwIy4CMwZXloDDKniM8LzR2_cVJoc_5Bx2eQYtJ9N6qoGu6rBUDwmZqTYaW1SaY5b5GXuzyannYKhbGDuuEWv3un9Bc1_0HydYdPAqMWtGNOF9bZvmBbAm2o49stUDOxtrUpezcizhLnde8IyWS6Uli_--9mOyD1spbTKl-RwuNqGV8CvBns8DqBjcudk-fXTFzy__7g6-wPe9iko |
| linkProvider | Elsevier |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELbKVgIuqLzahQJG4hptHMfO-lhVVFva7oVW6s3yEwWq7KrJHvpP-LmMY3slDqsicksyEyX25PPn8cwYoS--ohaIhCpsqWlR61IXomGiUKLygoMBEDVG-S754qb-dstu99BpzoUJYZUJ-yOmj2idrsxSa87WbTv7DnNxUQPbJsFIKWueoP1QnYpN0P7J-cVimQGZglGPVaREWPQEhZxBN4Z5dQABJpQMJc1YyJPUu0aoXQx0HInODtCLRCHxSXzLl2jPda_Q06u0SP4a_Q6xG7jtBvXL4ZXHtnWDun_Aebkf_7h7iI467DpbrGPN1x63PVaps0AoOGjhIYFU9nA6hn6CrWKABO8DPmLVWRDwYFIx_RFOcL_RwbHTR_Xg38UVzv7dN-jm7Ov16aJIGzAUBmZtQ1FRWlZCc68abpn3nInacG048wqIGmFzC4REW-UbN6-sNTWIMphQGcudAbB4iybdqnNHCKuSOm1qp5wO9WhgUJw7YhQttQKSVNEpornRpUnVycMmGXcyh6H9lLGrZOgqGaLxSD1FxVZrHatzPCLPcn_KnHkKWClh-HhEr9nq_WWd_6D5OZuNhB83rMaozq02vSSiBurUwLFbpiIAuQ0vaTVFh9Hmtt8JM2U254K9--93-4SeLa6vLuXl-fLiPXoe7sQsy2M0Ge437gPQrUF_TL_TH562KkQ |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=High+intake+of+dietary+advanced+glycation+end-products+is+associated+with+increased+arterial+stiffness+and+inflammation+in+subjects+with+type+2+diabetes&rft.jtitle=Nutrition%2C+metabolism%2C+and+cardiovascular+diseases&rft.au=Di+Pino%2C+A.&rft.au=Currenti%2C+W.&rft.au=Urbano%2C+F.&rft.au=Scicali%2C+R.&rft.date=2017-11-01&rft.pub=Elsevier+B.V&rft.issn=0939-4753&rft.volume=27&rft.issue=11&rft.spage=978&rft.epage=984&rft_id=info:doi/10.1016%2Fj.numecd.2017.06.014&rft.externalDocID=S0939475317301357 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0939-4753&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0939-4753&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0939-4753&client=summon |